Crinetics Pharmaceuticals, Inc. - stock earnings
CRNX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | - / -0.8400000000 | - | - / 260000 | - |
CRNX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -60.1 million USD | ? USD |
| 2023Q3 | -57.5 million USD | 346000 USD |
| 2023Q2 | -51.0 million USD | 988000 USD |
| 2023Q1 | -44.0 million USD | 2.7 million USD |
| 2022Q4 | -42.4 million USD | 709000 USD |
| 2022Q3 | -40.4 million USD | 458000 USD |
| 2022Q2 | -41.7 million USD | 439000 USD |
| 2022Q1 | -35.4 million USD | 3.1 million USD |
| 2021Q4 | -30.8 million USD | 1.1 million USD |
| 2021Q3 | -27.9 million USD | 6227 USD |
| 2021Q2 | -26.1 million USD | 5602 USD |
| 2021Q1 | -22.9 million USD | ? USD |
| 2020Q4 | -21.6 million USD | ? USD |
| 2020Q3 | -18.3 million USD | ? USD |
| 2020Q2 | -16.5 million USD | ? USD |
| 2020Q1 | -17.4 million USD | 71000 USD |
| 2019Q4 | -14.5 million USD | 321000 USD |
| 2019Q3 | -14.4 million USD | 505000 USD |
| 2019Q2 | -12.4 million USD | ? USD |
| 2019Q1 | -9.0 million USD | 367000 USD |
| 2018Q4 | -8.5 million USD | 781000 USD |
| 2018Q3 | -7.6 million USD | 548000 USD |
| 2018Q2 | -5.6 million USD | 657000 USD |
| 2018Q1 | -5.5 million USD | 442000 USD |
| 2017Q4 | -2.5 million USD | 528000 USD |
| 2017Q3 | -2.4 million USD | 640000 USD |
| 2017Q2 | -1.6 million USD | 832000 USD |
| 2017Q1 | -2.6 million USD | 45000 USD |
| 2016Q4 | -6.0 million USD | 589000 USD |
CRNX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -214.5 million USD | 4.0 million USD |
| 2022 | -160.0 million USD | 4.7 million USD |
| 2021 | -106.7 million USD | 1.1 million USD |
| 2020 | -72.9 million USD | 71000 USD |
| 2019 | -49.5 million USD | 1.2 million USD |
| 2018 | -27.1 million USD | 2.4 million USD |
| 2017 | -9.2 million USD | 2.0 million USD |
| 2016 | -6.0 million USD | 589000 USD |
CRNX
Price: $47.20
52 week price:
Earnings Per Share: -3.69 USD
P/E Ratio: -10.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 265100
Market Capitalization: 3.7 billion